IKT
#3210
Inhibikase Therapeutics, Inc. - Common Stock
2.3 8 USD
+0.03%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+3.03%
Variación mensual
+8.68%
Variación en los últimos 6 meses
+24.61%
Cambio anual
+36.00%
Cierres anteriores
2.3 1
Open
2.3 8
Mínimo
2.3 8
Máximo
2.3 8
Volumen
50
Financials
- Market Capitalization 332.1 M
- Employee 35
- Founded 2008
- CEO N/A
- Website www.inhibikase.com
- Headquarter Delaware, United States
- FIGI BBG005TP2339
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-4.61
Relación precio/flujo de caja
54.94
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3195 |  FHTX Foghorn Therapeutics Inc. - Common Stock | 5.69 USD | -0.87% | -16.93% | +25.05% | +39.46% | 337.90 M USD | ||
| 3198 |  SABS SAB Biotherapeutics, Inc. - Common Stock | 3.70 USD | -0.27% | -2.63% | +3.06% | +70.51% | 336.65 M USD | ||
| 3223 |  VNDA Vanda Pharmaceuticals Inc. - Common Stock | 5.42 USD | +0.37% | -0.18% | +6.27% | -1.99% | 327.71 M USD | ||
| 3253 |  IRD Opus Genetics, Inc. - Common Stock | 3.83 USD | +5.80% | -7.71% | +2.96% | +2.96% | 318.64 M USD |